Epigenetic Alterations in Immune Cells of Systemic Lupus Erythematosus and Therapeutic Implications
David E. Adams(Cincinnati Children's Hospital Medical Center), Wen-Hai Shao(University of Cincinnati)
Cited by 38
Related Papers
Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease
|Arthritis Research & Therapy|2020|36
Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis
|The Journal of Immunology|2016|23
Axl regulated survival/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis
|Arthritis Research & Therapy|2022|5
WDFY1-expressing follicular dendritic cells play a critical role in lupus development in cGVHD mouse model
|The Journal of Immunology|2025|1